Celularity Inc (CELU): debt financing — Celularity signs $10M standby equity deal and $3.15M convertible note with Yorkville

Celularity Inc

SEPA allows Celularity to sell up to $10M of common stock to Yorkville over 36 months at 97% of VWAP.
Yorkville provides $3.15M convertible note (8% interest, matures Mar 13, 2025) with conversion price initially $6.3171, resets to VWAP floor $2.4898.
Existing lenders RWI and Starr forbear defaults in exchange for 100bps interest increase and warrants (RWI: 300k shares at $5.895; Starr: reprice to $5.895).
Registration statement for Yorkville resale to be filed by May 3, 2024; no advances or conversions until effective.
Proceeds used for working capital; issuance capped at 19.99% of outstanding shares under Nasdaq rules.

item 1.01 item 2.03 item 3.02 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Celularity Inc incurred convertible notes of $3.15 million convertible promissory note for $2.99 million in cash with YA II PN, LTD at annual rate equal to 8.0% (increased to 18.0% in the event of default) maturing March 13, 2025.

Instrument: convertible notes
Principal: $3.15 million convertible promissory note for $2.99 million in cash
Counterparty: YA II PN, LTD
Rate: annual rate equal to 8.0% (increased to 18.0% in the event of default)
Maturity: March 13, 2025
Event: incurrence

Exact text from the filing

Upon entry into the SEPA, Celularity issued Yorkville a $3.15 million convertible promissory note for $2.99 million in cash (after a 5% original issue discount), or the Initial Advance. The note bears interest at an annual rate equal to 8.0% (increased to 18.0% in the event of default as provided in the note), and matures March 13, 2025.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Celularity Inc entered into Registration Rights Agreement with YA II PN, LTD (effective 2024-03-13).

Action: entry
Counterparty: YA II PN, LTD
Effective: 2024-03-13

Exact text from the filing

in connection with the entry into the SEPA, on March 13, 2024, Celularity entered into a registration rights agreement with Yorkville

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Celularity Inc entered into Standby Equity Purchase Agreement with YA II PN, LTD valued at up to $10.0 million (effective 2024-03-13).

Action: entry
Agreement: equity purchase
Counterparty: YA II PN, LTD
Value: up to $10.0 million
Effective: 2024-03-13

Exact text from the filing

On March 13, 2024, Celularity Inc., or Celularity, entered into a Standby Equity Purchase Agreement, or the SEPA, with YA II PN, LTD, a Cayman Islands exempt limited partnership, or Yorkville.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Celularity Inc entered into RWI Forbearance Agreement with Resorts World Inc Pte Ltd (effective 2024-03-13).

Action: entry
Agreement: credit facility
Counterparty: Resorts World Inc Pte Ltd
Effective: 2024-03-13

Exact text from the filing

On March 13, 2024, Celularity and Resorts World Inc Pte Ltd, or RWI, entered into a forbearance agreement, or the RWI Forbearance Agreement, with respect to the Second Amended and Restated Loan Agreement

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Celularity Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-010134

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.